Professor Joachim Kohn�s successful collaboration with REVA Medical Inc to develop a biodegradable stent for coronary artery disease treatment was highlighted by the NIBIB as a major advance. The research was supported by NIBIB, REVA Medical Inc., and the New Jersey Center for Biomaterials. Details can be found at www.nibib.nih.giv/eAdvances/92104.htm